NICOTINELL 14mg 24h patch

Land: Israël

Taal: Engels

Bron: Ministry of Health

Koop het nu

Download Productkenmerken (SPC)
27-03-2018

Werkstoffen:

NICOTINE

Beschikbaar vanaf:

GSK CONSUMER HEALTHCARE, ISRAEL LTD

ATC-code:

N07BA01

farmaceutische vorm:

PATCHES

Samenstelling:

NICOTINE 35 MG

Toedieningsweg:

TRANSDERMAL

Prescription-type:

Not required

Geproduceerd door:

GSK CONSUMER HEALTHCARE SCHWEIZ AG, SWITZERLAND

Therapeutische categorie:

NICOTINE

Therapeutisch gebied:

NICOTINE

therapeutische indicaties:

Aid to smoking cessation.

Autorisatie datum:

2012-05-31

Productkenmerken

                                _ _
_ _
_ _
_ _
_The format of this leaflet was determined by the Ministry of Health
and its content was checked and approved in Februdary 2017 _
_ _
1.
NAME OF THE MEDICINAL PRODUCT
NICOTINELL
7mg/24h patch
NICOTINELL
14mg/24h patch
NICOTINELL
21mg/24h patch
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each Nicotinell 7MG/24H PATCH patch contains 17.5 mg S(-)-nicotine
which provides an average
absorption rate of 7 mg nicotine in 24 hours.
Each Nicotinell 14MG/24H PATCH patch contains 35.0 mg S(-)-nicotine
which provides an average
absorption rate of 14 mg nicotine in 24 hours.
Each Nicotinell 21MG/24H PATCH patch contains 52.5 mg S(-)-nicotine
which provides an average
absorption rate of 21 mg nicotine in 24 hours.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Transdermal patches
The Nicotinell patch is a transdermal therapeutic system, consisting
of a round, flat, matrix-type self-
adhesive, yellowish-ochre coloured patch. It is protected by a
rectangular metallic release liner
backing to be discarded before application.
Nicotinell 7MG/24H PATCH patch 7mg/24 hour has a drug releasing area
of 10 cm
2
and is printed
CG CWC on the patch surface.
Nicotinell 14MG/24H PATCH patch 14mg/24 hour has a drug releasing area
of 20 cm
2
and is printed
CG FEF on the patch surface.
Nicotinell 21MG/24H PATCH patch 21mg/24 Hour has a drug releasing area
of 30 cm
2
and is printed
CG EME on the patch surface.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Aid to smoking cessation
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Adults:
For individuals smoking 20 cigarettes or more a day, it is recommended
that treatment be started with
Nicotinell 21MG/24H PATCH (Step 1) once daily, applied to a dry
non-hairy area of the skin on the
trunk or upper arm. Those smoking less than this are recommended to
start with Nicotinell 14MG/24H
PATCH (Step 2). Sizes of 30cm
2
, 20cm
2
and 10cm
2
are available to permit gradual withdrawal of
nicotine replacement, using treatment periods of 3-4 weeks (for each
size). The siz
                                
                                Lees het volledige document
                                
                            

Documenten in andere talen

Bijsluiter Bijsluiter Hebreeuws 27-03-2018

Zoekwaarschuwingen met betrekking tot dit product

Bekijk de geschiedenis van documenten